Ingrid Garajova

20PUBLICATIONS
108CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous systemCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 27, 2026
Longitudinal Circulating Nerve Growth Factor in Pancreatic Ductal Adenocarcinoma: An Exploratory Study of Postoperative Recurrence and First-Line Disease Control.

|Sep 26, 2026
Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma.

|Sep 26, 2026
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

|Sep 22, 2025
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: Recapitulating Its Importance and Defining Future Directions.

Martin Lovecek, Esra Dirimtekin, Ingrid Garajová

|Jan 08, 2025
Targeting Perineural Invasion in Pancreatic Cancer.

Ingrid Garajová, Elisa Giovannetti

|Aug 28, 2024
Focus on Pancreatic Cancer Microenvironment.

Fabiana Pratticò, Ingrid Garajová

Pageof 4

Frequent Collaborators

7 joint publications

Elisa Giovannetti

7 joint publications

Fabio Gelsomino

5 joint publications

Francesco Tovoli

4 joint publications

Alessandro Granito